DELISA is a highly sensitive digital ELISA analysis platform utilizing magnetic particle technology for multiplex immunoassay. It enables quantitative detection of disease biomarkers including vitamin D, Alzheimer's markers, and cardiac troponin for clinical diagnostics. The platform delivers compre...
Manufactured by
Seoul, South Korea
Small Machines Co., Ltd. is a biotechnology company based on the development of advanced on-site in vitro diagnostics and medical devices, merged by a digital healthcare platform. The innovations that Small Machines brings are built on the foundations of the convergence of NT, IT, and BT technologies. A pioneer in the field of POCT that owns the technology to develop and manufacture the world's best microfluid chips SmallMachines possesses a key piece of Bio-MEMS technology that seamlessly integrates biotechnology with Micro-electro Mechanical Systems(MEMS), which is heralded as the most advanced technology in the 21st century. To realize this technology, SmallMachines operation encompasses R D, production, and sales of life-science lab equipment, in vitro diagnostic medical devices, and related consumables and solutions. Our company has about 100 patents related to NT-IT-BT (nanotechnology-information technology- biotechnology) convergence technology in Korea and abroad. In particular, we possess the technology for a key platform called lab-on-a-chip, which integrates laboratory processes on a meticulously designed microfluid chip, making significant contributions to the fields of medical and life science engineering. What we bring to the table our mission Smallmachines is focused on Open Innovation. We have began our journey with our core Bio-MEMS technology and have progressed on to analytical equipments: CELLOP, DELISA, and WHOPE. Furthermore, we have developed a CDSS Platform for early diagnosis of diseases and personalized healthcare facilitated through the data gathered by our equipment. SmallMachines brings a comprehensive and unique solution to modern day healthcare by providing both innovative hardware and software for the mission of affordable, universal healthcare.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Biomerica, Inc.
United States · 1 relevant product
S&T BioMed CO., LTD.
Taiwan · 1 relevant product
ZIODIA Co., Ltd.
South Korea · 3 relevant products
Shenzhen YHLO Biotech Co., Ltd.
China · 2 relevant products
Guangzhou Wondfo Biotech Co., Ltd.
China · 1 relevant product
Jiangsu Sunlant Bioengineering Co., Ltd.
China · 1 relevant product
Micropoint Bioscience, Inc.
United States · 1 relevant product
Pictor
United States · 1 relevant product
Anhui Huibang Biological Engineering Co., Ltd.
China · 1 relevant product
Response Biomedical
Canada · 1 relevant product
27 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 44 closest product alternatives
Biomerica, Inc. · United States
A point-of-care diagnostic platform supporting manual to high-throughput ELISA testing with easy automation capabilities. Enables laboratory-accurate results at the point-of-care.
S&T BioMed CO., LTD. · Taiwan
Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.
ZIODIA Co., Ltd. · South Korea
A diagnostic device platform based on MEMS (Micro-Electro-Mechanical System) core technology that enables precise control and detection of minute whole blood samples and implements real-time analysis at the point-of-care level through Lab-on-a-Chip technology. The platform is designed for medical chain diagnosis devices and related solutions.
Shenzhen YHLO Biotech Co., Ltd. · China
A comprehensive technology platform utilizing chemiluminescence immunoassay methodology for in vitro diagnostic testing. The platform enables sensitive and specific detection of various clinical markers including reproductive, autoimmune, infectious disease, and metabolic parameters.
Shenzhen YHLO Biotech Co., Ltd. · China
An integrated biochemistry testing platform for clinical laboratory diagnostics. The system encompasses multiple biochemical assays approved for clinical use in patient sample analysis.
ZIODIA Co., Ltd. · South Korea
A platform for immune diagnosis devices based on Quantum Dot fluorescence measurement mode technology. It includes Quantum Dot labeled detection kits for enhanced sensitivity, precise analysis, and multiplex analysis capabilities. The platform offers both Gold Type and Quantum Dot Type kits with sensitivity down to ng/ml levels and 500-1,000 fold higher accuracy compared to gold standard detection methods.
Guangzhou Wondfo Biotech Co., Ltd. · China
Chemiluminescence diagnostic platform for quantitative and qualitative analysis of biomarkers in patient samples. Delivers sensitive detection capabilities for clinical laboratory and point-of-care applications.
Jiangsu Sunlant Bioengineering Co., Ltd. · China
A microarray-based chemiluminescence immunoassay platform using hard-substrate glass slides as carriers with covalently bound monoclonal antibodies. The platform features integrated positive and negative quality control points, multi-parameter detection with up to 56 array points, and a sandwich immunoassay methodology. It combines high-sensitivity chemiluminescence detection with high-throughput biochip technology using an integrated photoelectric sensor to read all signal points simultaneously.
Micropoint Bioscience, Inc. · United States
A microfluidic-based platform for lab-level accuracy point-of-care testing. The platform serves as the foundation for multiple specialized diagnostic solutions including cardiovascular, diabetes and kidney injury, inflammation, and fertility testing applications.
ZIODIA Co., Ltd. · South Korea
Compact platform for performing in vitro diagnostic testing utilizing advanced microfluidic technology. Delivers laboratory-quality results while reducing time to diagnosis and associated testing costs.
Pictor · United States
96-well format targeted proteomics platform for biomarker detection with high sensitivity and specificity. Delivers results in under 2 hours and supports multiple sample types including blood, plasma, saliva, and milk without reconfiguration.
Anhui Huibang Biological Engineering Co., Ltd. · China
Quantum dot-based detection platform for in vitro diagnostic testing of urine biomarkers. Enables multi-channel composite analysis for early detection of diabetic nephropathy and premature rupture of membranes through dry-reagent immunoassay technology. Supports both clinical laboratory quantification and point-of-care patient self-testing with mobile device image capture and server-based result analysis.
32 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products